NFKB1 and prostate carcinoma: Studies conducted thus far in prostate cancer provide evidence that in cells with a gain of function in Akt due to loss of PTEN activity, the transcriptional activity of NF-κB is upregulated, and inhibition of Akt interferes with this upregulation of NF-κB [26,27,28].